EATON VANCE MANAGEMENT - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 144 filers reported holding FIBROGEN INC in Q1 2017. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
EATON VANCE MANAGEMENT ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2022$1,229,000
+23.1%
94,4780.0%0.00%
+100.0%
Q2 2022$998,000
-12.1%
94,4780.0%0.00%0.0%
Q1 2022$1,136,000
-14.7%
94,4780.0%0.00%
-50.0%
Q4 2021$1,332,000
+37.9%
94,4780.0%0.00%
+100.0%
Q3 2021$966,000
-61.6%
94,4780.0%0.00%
-66.7%
Q2 2021$2,516,000
-23.3%
94,4780.0%0.00%
-40.0%
Q1 2021$3,279,000
-53.2%
94,478
-50.0%
0.01%
-16.7%
Q4 2020$7,008,000
+80.4%
188,964
+100.0%
0.01%
-14.3%
Q3 2020$3,885,000
+1.5%
94,4820.0%0.01%
-12.5%
Q2 2020$3,829,000
+16.6%
94,482
-0.1%
0.01%0.0%
Q1 2020$3,285,000
-18.9%
94,540
+0.1%
0.01%0.0%
Q4 2019$4,052,000
+16.0%
94,481
+0.0%
0.01%
+14.3%
Q3 2019$3,494,000
+48.7%
94,478
+81.7%
0.01%
+40.0%
Q2 2019$2,349,000
-16.9%
52,0000.0%0.01%
-16.7%
Q1 2019$2,826,000
+42.0%
52,000
+20.9%
0.01%
+20.0%
Q4 2018$1,990,000
-23.8%
43,0000.0%0.01%
-16.7%
Q3 2018$2,612,000
-3.0%
43,0000.0%0.01%0.0%
Q2 2018$2,692,000
-32.3%
43,000
-50.0%
0.01%
+20.0%
Q1 2018$3,974,000
+95.0%
86,000
+100.0%
0.01%0.0%
Q4 2017$2,038,000
-11.9%
43,0000.0%0.01%
-16.7%
Q3 2017$2,313,000
+66.5%
43,0000.0%0.01%
+50.0%
Q2 2017$1,389,000
+145.0%
43,000
+87.0%
0.00%
+100.0%
Q1 2017$567,00023,0000.00%
Other shareholders
FIBROGEN INC shareholders Q1 2017
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$6,190,0001.33%
Intercontinental Wealth Advisors, LLC 191,300$1,955,0000.46%
BHK Investment Advisors, LLC 70,300$718,0000.30%
Rhenman & Partners Asset Management AB 200,000$2,044,0000.14%
Omega Fund Management, LLC 130,646$1,150,0000.13%
PRIMECAP MANAGEMENT CO/CA/ 12,791,757$130,732,0000.09%
Jump Financial, LLC 96,300$984,0000.07%
Walleye Capital LLC 244,714$2,501,0000.07%
JACOBS LEVY EQUITY MANAGEMENT, INC 999,766$10,218,0000.07%
FARALLON CAPITAL MANAGEMENT LLC 1,446,212$14,780,0000.07%
View complete list of FIBROGEN INC shareholders